Assisted dying bill: What is in proposed law?
The proposed law would allow some terminally ill adults to end their own lives. But there are requirements.
another news portal
The proposed law would allow some terminally ill adults to end their own lives. But there are requirements.
People affected by rare blood clots say they feel they have been airbrushed out of the pandemic.
When the history of this sad era is written, MAHA doctors will be disgraced pariahs and cautionary tales. Everyone else should be remembered based only
For the first time, researchers show that tirzepatide – the active ingredient in the diabetes and weight-loss drug Mounjaro – reduces alcohol intake as well
A Japanese study of more than 7,400 patients has identified a genetic mismatch that sharply increases the risk of severe acute graft-versus-host disease (GVHD) following
That Time of the Month with Naga Munchetty, Dr Nighat Arif and Dr Christine Ekechi
For adults with asthma, having fans, air purifiers or other ventilation and exhaust systems – especially in kitchens and bathrooms – is one of the
A single exposure to a toxic fungicide during pregnancy can increase the risk of disease for 20 subsequent generations – with inherited health problems worsening
A new study provides hope that smarter timing of cancer treatments could improve cure rates.
For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives.
Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new
The protein “neurofilament light chain” (NfL) – studied in humans in the context of neurodegenerative diseases and aging – is also detectable in the blood
Acinetobacter baumannii is a bacteria which can become a virulent killer in health-care settings among severely ill patients. The germ has rapidly developed drug resistance
A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled “Gastrointestinal toxicity of targeted cancer therapies in the United States: